Results of treatment of endometrial hyperplasia with the use of non-steroidal anti-inflammatory agents against the background of chronic endometritis and without accompanying inflammatory process

V. Abdullaiev, A. Hryhorenko
{"title":"Results of treatment of endometrial hyperplasia with the use of non-steroidal anti-inflammatory agents against the background of chronic endometritis and without accompanying inflammatory process","authors":"V. Abdullaiev, A. Hryhorenko","doi":"10.24061/2413-0737.xxvi.3.103.2022.1","DOIUrl":null,"url":null,"abstract":"The paper examines the treatment results of women with non-atypical hyperplastic endometrial processes with the use of anti-inflammatory drugs for a long time. The purpose of our study was to evaluate the effectiveness of the proposed treatment regimen depending on the type of hyperplastic processes and their connection with chronic inflammatory processes in the endometrium. Material and methods. We examined 101 women, of which 29 women with hyperplastic processes without accompanying chronic endometritis were included in experimental group №1, 49 women with a combination of hyperplastic processes and chronic endometritis were included in experimental group №2, the control group included 23 women with hyperplastic processes without chronic endometritis. The control group received only hormonal therapy, the experimental group №1 received long-term anti-inflammatory nonsteroidal drugs in addition to hormonal correction, the experimental group №2 received a course of broad-spectrum antibiotics in addition to anti-inflammatory drugs. Treatment effectiveness was evaluated 6, 12 and 24 months after hysteroscopy.Results of the study. 24 months after hysteroscopy in the control group, we observed 43.5% recurrence of hyperplastic endometrial processes, while at the same time when using anti-inflammatory therapy with non-steroidal drugs (experimental group No. 1), after 24 months we observed 20.7% recurrence ( p<0.05) and in women with a combination of GE and HE (experimental group No. 2) with the use of anti-inflammatory nonsteroidal drugs and antibiotics, the relapse rate was 22.4% (p<0.05). The results of additional studies and the use of statistical methods have proven that the effectiveness of treatment is related to the applied methods and is not accidental.Conclusions. The use of non-steroidal anti-inflammatory drugs increases the effectiveness of anti-recurrence conservative treatment of women with hyperplastic processes after hysteroscopy.","PeriodicalId":9270,"journal":{"name":"Bukovinian Medical Herald","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bukovinian Medical Herald","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24061/2413-0737.xxvi.3.103.2022.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The paper examines the treatment results of women with non-atypical hyperplastic endometrial processes with the use of anti-inflammatory drugs for a long time. The purpose of our study was to evaluate the effectiveness of the proposed treatment regimen depending on the type of hyperplastic processes and their connection with chronic inflammatory processes in the endometrium. Material and methods. We examined 101 women, of which 29 women with hyperplastic processes without accompanying chronic endometritis were included in experimental group №1, 49 women with a combination of hyperplastic processes and chronic endometritis were included in experimental group №2, the control group included 23 women with hyperplastic processes without chronic endometritis. The control group received only hormonal therapy, the experimental group №1 received long-term anti-inflammatory nonsteroidal drugs in addition to hormonal correction, the experimental group №2 received a course of broad-spectrum antibiotics in addition to anti-inflammatory drugs. Treatment effectiveness was evaluated 6, 12 and 24 months after hysteroscopy.Results of the study. 24 months after hysteroscopy in the control group, we observed 43.5% recurrence of hyperplastic endometrial processes, while at the same time when using anti-inflammatory therapy with non-steroidal drugs (experimental group No. 1), after 24 months we observed 20.7% recurrence ( p<0.05) and in women with a combination of GE and HE (experimental group No. 2) with the use of anti-inflammatory nonsteroidal drugs and antibiotics, the relapse rate was 22.4% (p<0.05). The results of additional studies and the use of statistical methods have proven that the effectiveness of treatment is related to the applied methods and is not accidental.Conclusions. The use of non-steroidal anti-inflammatory drugs increases the effectiveness of anti-recurrence conservative treatment of women with hyperplastic processes after hysteroscopy.
慢性子宫内膜炎背景下使用非甾体抗炎药治疗子宫内膜增生,无伴随炎症过程的结果
本文探讨了长期应用抗炎药物治疗非典型子宫内膜增生性病变的效果。我们研究的目的是评估所提出的治疗方案的有效性,这取决于增生过程的类型及其与子宫内膜慢性炎症过程的关系。材料和方法。我们检查了101名妇女,其中29名妇女增生性过程没有伴随慢性子宫内膜炎被包括在实验组№1,49名妇女合并增生性过程和慢性子宫内膜炎被包括在实验组№2,对照组包括23名妇女增生性过程没有慢性子宫内膜炎。对照组仅接受激素治疗,实验组№1在激素纠正的基础上接受长期抗炎非甾体药物治疗,实验组№2在抗炎药物基础上接受广谱抗生素治疗。分别于宫腔镜检查后6、12、24个月评价治疗效果。研究结果。对照组宫腔镜术后24个月子宫内膜增生过程复发率为43.5%,同时采用非甾体类药物抗炎治疗(实验组1),24个月复发率为20.7% (p<0.05), GE联合HE联合使用非甾体类药物和抗生素治疗(实验组2),复发率为22.4% (p<0.05)。其他研究的结果和统计方法的使用已经证明,治疗的有效性与所采用的方法有关,而不是偶然的。使用非甾体抗炎药增加了宫腔镜后增生过程女性保守治疗的抗复发效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信